Growth Metrics

Eli Lilly (LLY) Net Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1,744.00
Mar 31, 2024 -4,670.00
Dec 31, 2023 2,334.00
Sep 30, 2023 -166.00
Jun 30, 2023 2,172.00
Mar 31, 2023 1,831.00
Dec 31, 2022 5,169.00
Sep 30, 2022 1,109.00
Jun 30, 2022 -263.00
Mar 31, 2022 2,648.00
Dec 31, 2021 818.00
Sep 30, 2021 141.00
Jun 30, 2021 679.00
Mar 31, 2021 1,087.00
Mar 31, 2019 5,673.00
Dec 31, 2018 -1,230.00
Sep 30, 2018 -1,979.00
Jun 30, 2018 -2,085.00
Mar 31, 2018 -2,662.00
Dec 31, 2017 -3,889.00
Sep 30, 2017 -1,455.00
Jun 30, 2017 82.00
Mar 31, 2017 -2,017.00
Dec 31, 2016 -90.00
Sep 30, 2016 -512.00
Jun 30, 2016 -531.00
Mar 31, 2016 -904.00
Dec 31, 2015 -1,036.00
Sep 30, 2015 -762.00
Jun 30, 2015 -1,207.00
Mar 31, 2015 -1,135.00
Dec 31, 2014 -735.00
Sep 30, 2014 -721.00
Jun 30, 2014 -703.00
Mar 31, 2014 -1,047.00